JuhnSKJungTTKLinJLeeYWGiebinkGSAdamsGL. The role of arachidonic acid metabolites in the pathogenesis of otitis media. In: TakasakaTYuasaRHozawaK, eds. Recent advances in otitis media. Proceedings of Otitis Media 2001 in Sendai. Bologna, Italy: Monduzzi Editore, 2001:65–70.
2.
TuomanenETomaszAHengstlerBZakO. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J Infect Dis1985;151:535–40.
3.
TuomanenEI. Pathogenesis of pneumococcal inflammation: Otitis media. Vaccine2000;19(suppl 1): S38–S40.
4.
Ripley-PetzoldtMLGiebinkGSJuhnSKAeppliDTomaszATuomanenE. The contribution of pneumococcal cell wall to pathogenesis of experimental otitis media. J Infect Dis1988;157:245–55.
5.
CarlsenBDKawanaCKawanaATomaszAGiebinkGS. Role of the bacterial cell wall in middle ear inflammation caused by Streptococcus pneumoniae. Infect Immun1992;60:2850–4.
6.
JewettBSPrazmaJPHunterSE. Systematic reactivation of otitis media in a rat model. Otolaryngol Head Neck Surg1999;121:7–12.
7.
SatoKQuarteyMKLiebelerCLLeCTGiebinkGS. Roles of autolysin and pneumolysin in middle ear inflammation caused by a type 3 Streptococcus pneumoniae strain in the chinchilla otitis media model. Infect Immun1996;64:1140–5.
8.
YoshidaKIchimiyaISuzukiMMogiG. Effect of proinflammatory cytokines on cultured spiral ligament fibrocytes. Hear Res1999;137:155–9.
9.
HimiTSuzukiTKodamaHTakezawaHKatauraA. Immunologic characteristics of cytokines in otitis media with effusion. Ann Otol Rhinol Laryngol Suppl1992;101(suppl 157): 21–5.
10.
JuhnSKTolanCJGarvisWJCrossDSGiebinkGS. The levels of IL-1 beta in human middle ear effusions. Acta Otolaryngol Suppl (Stockh)1992(suppl 493):37–42.
11.
ForseniMMelhusARyanAFBagger-SjobackDHultcrantzM. Detection and localization of interleukin-6 in the rat middle ear during experimental acute otitis media, using mRNA in situ hybridization and immunohistochemistry. Int J Pediatr Otorhinolaryngol2001;57:115–21.
12.
HebdaPAAlperCMDoyleWJBurckartGJDivenWFZeeviA. Upregulation of messenger RNA for inflammatory cytokines in middle ear mucosa in a rat model of acute otitis media. Ann Otol Rhinol Laryngol1998;107:501–7.
13.
HebdaPAPiltcherOSwartsJD. Cytokine profiles in a rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection. Laryngoscope2002;112:1657–62.
14.
MelhusARyanAF. Expression of cytokine genes during pneumococcal and nontypeable Haemophilus influenzae acute otitis media in the rat. Infect Immun2000;68:4024–31.
15.
WinterAJComisSDOsborneMP. A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental pneumococcal meningitis in guinea pigs. Infect Immun1997;65:4411–8.
16.
LiWLinJAdamsGLJuhnSK. Expression of inducible nitric oxide synthase (iNOS) in middle ear epithelial cells by IL-1 beta and TNF-alpha. Int J Pediatr Otorhinolaryngol2000;55:91–8.
17.
RyanAFBennettT. Nitric oxide contributes to control of effusion in experimental otitis media. Laryngoscope2001;111:301–5.
18.
BallSSPrazmaJDaisDRosbeKWPillsburyHC. Nitric oxide: A mediator of endotoxin-induced middle ear effusions. Laryngoscope1996;106:1021–7.
19.
JohnEORussellPTNamBHJinnTHJungTT. Concentration of nitric oxide metabolites in middle ear effusion. Int J Pediatr Otorhinolaryngol2001;60:55–8.
20.
JuhnSKJungTTKLinJRheeCK. Effect of inflammatory mediators on middle ear pathology and inner ear function. Ann NY Acad Sci1997;830:130–42.
21.
GoycooleaMVMuchowDSchachernP. Experimental studies on round window structure: Function and permeability. Laryngoscope1988;98(suppl 44):1–20.
22.
McDermottJCFaustiSAFreyRH. Effects of middle-ear disease and cleft palate on high-frequency hearing in children. Audiology1986;25:136–48.
23.
LopponenHSorriMPekkalaRPennaJ. Secretory otitis media and high-frequency hearing loss. Acta Otolaryngol Suppl (Stockh)1992(suppl 493):99–107.
24.
HunterLLMargolisRHRykkenJRLeCTDalyKAGiebinkGS. High frequency hearing loss associated with otitis media. Ear Hear1996;17:1–11.
25.
MargolisRHSalyGLHunterLL. High-frequency loss and wideband middle ear impedance in children with otitis media histories. Ear Hear2000;21:206–11.
26.
MorizonoTGiebinkGSPaparellaMMSikoraMASheaD. Sensorineural hearing loss in experimental purulent otitis media due to Streptococcus pneumoniae. Arch Otolaryngol1985;111:794–8.
27.
DeMariaTF. Localization of nontypeable Haemophilus influenzae endotoxin in the middle and inner ear during experimental otitis media. Acta Otolaryngol (Stockh)1999;119:583–7.
28.
HuangMDulonDSchachtJ. Outer hair cells as potential targets of inflammatory mediators. Ann Otol Rhinol Laryngol Suppl1990;99(suppl 148):35–8.
29.
WangHXingCCaiY. Effect of experimental immunological otitis media on inner ear [in Chinese]. Lin Chuang Er Bi Yan Hou Ke Za Zhi1997;11:296–8.
30.
StenqvistMAnnikoMRask-AndersenH. Middle ear mucosa changes following exposure to Pseudomonas aeruginosa exotoxin A. Eur Arch Otorhinolaryngol1999;256:484–90.
31.
HodgesKBPennyJEBrownRDHenleyCM. Scanning electron microscopy of cochlea in rats with Streptococcus pneumoniae otitis media. Arch Otolaryngol1984;110:429–36.
32.
SchachernPAPaparellaMMHybertsonRSanoSDuvallAJIII. Bacterial tympanogenic labyrinthitis, meningitis, and sensorineural damage. Arch Otolaryngol Head Neck Surg1992;118:53–7.
33.
CookRDPostmaDSBrinsonGMPrazmaJPillsburyHC. Cytotoxic changes in hair cells secondary to pneumococcal middle-ear infection. J Otolaryngol1999;28:325–31.
34.
ComisSDOsborneMPStephenJ. Cytotoxic effects on hair cells of guinea pig cochlea produced by pneumolysin, the thiol activated toxin of Streptococcus pneumoniae. Acta Otolaryngol (Stockh)1993;113:152–9.
35.
EngelFBlatzRKellnerJPalmerMWellerUBhadkiS. Breakdown of the round window membrane permeability barrier evoked by streptolysin O: Possible etiologic role in development of sensorineural hearing loss in acute otitis media. Infect Immun1995;63:1305–10.
36.
KuboTAnnikoMStenqvistMHsuW. Interleukin-2 affects cochlear function gradually but reversibly. J Otorhinolaryngol Relat Spec1998;60:272–7.
IchimiyaISuzukiMHiranoTMogiG. The influence of pneumococcal otitis media on the cochlear lateral wall. Hear Res1999;131:128–34.
39.
IchimiyaIYoshidaKHiranoTSuzukiMMogiG. Significance of spiral ligament fibrocytes with cochlear inflammation. Int J Pediatr Otolaryngol2000;56:45–51.
40.
HessABlochWHuverstuhlJ. Expression of inducible nitric oxide synthase (iNOS/NOS II) in the cochlea of guinea pigs after intratympanical endotoxin-treatment. Brain Res1999;830:113–22.
41.
SoneMRusslieHQCanafaxDMPaparellaMM. Expression of intercellular adhesion molecule-1 in rat inner ear due to bacterial otitis media. Ann Otol Rhinol Laryngol1999;108:648–52.
42.
WatanabeKJinnouchiKHessAMichelOYagiT. Detection of apoptotic changes in the lipopolysaccharide (LPS)–treated cochlea of guinea pigs. Hear Res2001;158:116–22.
43.
AdamsJC. Clinical implications of inflammatory cytokines in the cochlea: A technical note. Otol Neurotol2002;23:316–22.
44.
JuhnSKLeeSHunterB. Characteristics of blood-labyrinth barrier. In: SantiPA, ed. ARO Abstracts, Daytona Beach, Fla, 2003:17.
45.
LauCBillingsPHarrisJKeithleyE. Effect of TNF on recruitment of cochlear inflammatory cells. In: SantiPA, ed. ARO Abstracts, Daytona Beach, Fla, 2003:267.
46.
HashimotoSBillingsPFiresteinGSHarrisJPKeithleyE. Contribution of innate immune response to cochlear inflammation. In: SantiPA, ed. ARO Abstracts, Daytona Beach, Fla, 2003:266.